Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,592.40
(
0.20%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
94.02
(
-2.04%
)
Bitcoin
70,789.00
(
-0.80%
)
News Focus
News Focus
Post# of 325
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jondoeuk

Send PM Follow Ignore
Followers 37
Posts 3508
Boards Moderated 1
Alias Born 10/24/2015

jondoeuk

Re: jondoeuk post# 311

Thursday, 10/30/2025 8:50:50 PM

Thursday, October 30, 2025 8:50:50 PM

Post# of 325
''The AATD program, CTX460, is the first investigational candidate to emerge from the SyNTase editing platform and the Company expects to initiate a clinical trial with CTX460 in mid-2026.'' https://finance.yahoo.com/news/crispr-therapeutics-presents-preclinical-data-120000376.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CRSP News
More CRSP News